Trial Profile
Facilitation Through Abciximab By drOpping Infusion Line in Patients Undergoing Coronary Stenting. SYNergy With Clopidogrel at High Loading dOse Regimen.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Abciximab (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Coronary stent thrombosis
- Focus Pharmacodynamics
- Acronyms FABOLUS
- 10 Jul 2009 New trial record